NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) is pleased to announce the Company has signed a Definitive Master Licensing Agreement (the Agreement) with Delta 9 Cannabis Inc. (TSXV: NINE) (OTC: VRNDF) (Delta 9) in a deal that opens the Canadian market to NanoSphere’s patented groundbreaking delivery technology.

If you were hoping for a rager, you were on the wrong private jet. A tropical storm had delayed the flight from Ottawa to Newfoundland by eight hours, and the mood on board Canopy Growth CEO Bruce Linton’s chartered Embraer Legacy 450 on the evening of October 16 was celebratory but cautious. At midnight that night, Canada would become the first G20 nation (and the second country in the world, after Uruguay) to legalize marijuana for adult recreational use. Linton, who had arguably more of the stuff to sell than anyone on the planet, was racing to get to his company’s flagship Tweed store in St. John’s, in the Newfoundland time zone, where clocks are somewhat inconceivably set a half hour ahead of the next easternmost time zone. If the plane’s all-too-apt ETA of 10:17 p.m.

Ontario looking to ship same-day pot ahead of bricks-and-mortar rollout

Cannabis stocks in the US and Canada were having a positive session on Thursday, trading in the opposite direction of the S&P 500 Index.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, climbed 1.5% to 263.78.

Buds:

The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCMKTS:TGODF) surged 10% to US$2.52 on the OTC Markets after announcing that the Ontario Superior Court of Justice has approved its spinoff of TGOD Acquisition Corp.

The proposed spinoff focuses on investments in the cannabis industry in Canada and internationally. The Green Organic Dutchman plans to distribute to its shareholders unit purchase warrants of TGOD Acquisition.

With the legalization of cannabis in this rapidly- growing industry, the cannabis market provides countless opportunities.

The Canadian marijuana stocks we’ve weeded out today are holdings companies that focus their investments on cannabis, taking advantage of the potential benefits the industry has to offer.

Leading investment crowdfunding platform OurCrowd is jumping into the hot cannabis sector. OurCrowd has launched a $30 million cannabis tech fund called 7thirty Opportunity Fund.

OurCrowd said it will build the “world’s leading global cannabis technology venture capital fund.” The new fund is said to be focused on cannabis technology companies in Medtech, Agtech, retail, e-commerce, marketplaces, SaaS solutions, and the deep-tech research in Cannabis. Headquartered in Boulder, Colorado – a state that has legalized recreational use of marijuana, the fund will be active globally and include activities in Israel, Canada, and the United States.

The global cannabis market is still in the early innings of a multi-year boom.

Thanks in large part to growing acceptance of cannabis - including Canada's legalization in October 2018, further U.S. state approval, and growing interest from corporate America the global market is expected to reach $146.4 billion by 2025, according to Grand View Research Inc. from $7.06 billion in 2016.

In addition, the growing adoption of cannabis in medical applications such as cancer, mental disorders, and chronic pain is expected to propel revenue growth even more. As millions of people living all over the world look to embrace its medicinal properties, marijuana companies are quickly gaining the attention of cannabis investors.

Investors in Village Farms International Inc.(TSX:VFF) saw a nice 20.39% rally in the stock price on Monday as the greenhouse operator and new cannabis grower released some welcome news of desired progress and announced new listing plans.

Why did the stock rally that much?

Village Farms updated the market that its Pure Sunfarms joint venture with Emerald Health Therapeutics has completed the conversion of a 1.1million square foot green house into cannabis production and has since made an application to Health Canada for production licensing.

Aphria vows to resist 'opportunistic offers' following Green Growth bid

With the legalization of recreational marijuana, more needs to be done to warn people of the health risks, including psychosis, a speaker told insurance claims professionals Tuesday.

“One of the things I am most disappointed about is that, in the communication around cannabis, we tend not to have really communicated the fact that – particularly if you are younger – there is a certain percentage of the population that has a genetic predisposition to psychosis if they take cannabis,” said Paula Allen, vice president of research and integrative solutions for Morneau Shepell Inc., a Toronto-based consulting firm that provides employee assistance programs.